Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

The retrospective cohort study included more than 130,000 people in the US. It reveals that the shingles vaccine (called ...

The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine ...

A recent study suggests that certain immunizations may unexpectedly protect against cognitive decline, potentially reducing ...

The U.S. FDA has approved a prefilled syringe presentation of GSK plc’s SHINGRIX for the prevention of shingles.

Shingrix has been administered in a two-step process. It involved combining two separate vials—a freeze-dried (lyophilized) powder containing the antigen, and a liquid adjuvant, by trained healthcare ...

GlaxoSmithKline has made a promising start to 2022 with a 32% rise in group sales, albeit measured against a downbeat first-quarter result in 2021. Vir Biotechnology-partnered COVID-19 antibody ...

Scientists behind a study suggesting GSK's RSV vaccine may be protective against dementia have said the adjuvant used in it may be responsible.

Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, ...

Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, sparking concerns among medical experts.

In addition to UBS, GlaxoSmithKline also received a Hold from TR | OpenAI – 4o’s Veda Pharmyne in a report issued today. However, on July 15, Bank of America Securities maintained a Sell rating on ...